Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 13, 711-726

Phages & Antibiotic Resistance: Are the Most Abundant Entities on Earth Ready for a Comeback?

Affiliations
Review

Phages & Antibiotic Resistance: Are the Most Abundant Entities on Earth Ready for a Comeback?

Colin Hill et al. Future Microbiol.

Abstract

Bacteriophages, which lost out to antibiotic therapy in the past, may be poised to make a comeback. Once discarded because of their narrow activity spectrum, it can now be viewed as a major advantage that these intracellular, self-replicating entities can exert their killing effect with minimal damage to the commensal microbiome. In eastern Europe, phages continue to be used both prophylactically and therapeutically to treat infections. More recently, much needed regulated clinical trials are underway with a view to restoring phage therapy as a tool for mainstream medicine, although current regulations may impede their full potential. One hundred years after their discovery, and amid an antibiotic resistance crisis, we must ask, what can be done to harness their full antibacterial potential?

Keywords: Escherichia coli; Pseudomonas aeruginosa; Staphylococcus aureus; antibiotic resistance; bacteriophage; clinical trials; phage resistance.

Similar articles

See all similar articles

Cited by 7 articles

See all "Cited by" articles

Publication types

MeSH terms

LinkOut - more resources

Feedback